chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHILLS; BURSITIS; BRUISING IN BLACK AND BLUE DISCOLOURATION AT RIGHT  ELBOW; This spontaneous report received from a patient concerned a 49 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy. The patient experienced drug allergy when treated with ibuprofen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 10:55 for prophylactic vaccination. Non-company suspect drugs included: prednisone (tablet, oral, batch number: Unknown) 50 mg, 1 time every 1 day, from 02-APR-2021 for bursitis. No concomitant medications were reported. On 01-APR-2021 15:55, the subject experienced bursitis. On 01-APR-2021 15:55, the subject experienced bruising in black and blue discoloration at right elbow. On 02-APR-2021 04:30, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with prednisone was withdrawn. The patient recovered from chills on 02-APR-2021, had not recovered from bruising in black and blue discoloration at right elbow, and the outcome of bursitis was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
I developed a really bad rash on my left arm, blisters on my left shoulder blade area, and blisters on my left side of my chest. I still experiencing pain the areas where the blisters appeared.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 12-JUN-2018, the patient was inadvertently vaccinated with an extra dose of VAQTA lot number N030286 and expiration date on 10-NOV-2018 for prophylaxis (strength, dose number, anatomical location and route of administration were not reported). No adverse effect was reported.
Expanding red area from quarter to palm size, very hot. Was on the way to M.D. We called MD for patient.
pain; Severe migraine; Herpes flare up; itchy; swelling; burned; blister; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Severe migraine), HERPES VIRUS INFECTION (Herpes flare up), PRURITUS (itchy), SWELLING (swelling) and SKIN BURNING SENSATION (burned) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced MIGRAINE (Severe migraine), HERPES VIRUS INFECTION (Herpes flare up), PRURITUS (itchy), SWELLING (swelling), SKIN BURNING SENSATION (burned) and BLISTER (blister). On an unknown date, the patient experienced PAIN (pain). On 27-Feb-2021, MIGRAINE (Severe migraine) had resolved. At the time of the report, HERPES VIRUS INFECTION (Herpes flare up), PRURITUS (itchy), SWELLING (swelling), SKIN BURNING SENSATION (burned) and BLISTER (blister) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment details included Patient was prescribed phenazopyridine 200mg, acyclovir 400mg TID, and a third 'antibiotic' that, he could not recall. Patient attempted to self medicate with an anti-itch topical spray but found no, relief..
Bleeding and pain at injection site; Droopy left side of face, pain in upper left jaw, below left eye, upper left arm and left shoulder/neck; Transient headache and pain in left leg with ankle swelling.
Information has been received from a nurse practitioner and a licensed practical nurse concerning a teenage female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil. Subsequently, the patient ended up crying and reported she had pain, when the vaccine was being administered, either the left or right arm and had some pain afterwards. Unspecified medical attention was sought. At the time of this report the patient had recovered from the events (date unknown). Additional information has been requested.
Received influenza vaccination in left deltoid, small amount of blood noted after injection but nothing else out of the ordinary. Noticed a bruise the next day and that the injection site was high and close to acromion process. Left upper arm/shoulder started to ache and had limited ROM, applied heat and took ibuprofen. Continued to ache and have limited ROM (particularly with abduction - pain). As of 10/18/18 not aching or bothering at night, but still have some limited ROM, although has improved. Will visit with healthcare professional next week if not improved.
Information has been received from a physician concerning a 12 year old male who on 12-NOV-1998 and 24-OCT-2001 was vaccinated with the first and second dose of MMR II, respectively. On 24-NOV-2009 the patient was diagnosed with mumps. The patient had left and right parotitis. Signs and symptoms included fever (103 F). First blood work performed on 24-NOV-2009 showed IgM <1:10, IgG 6.25 and serum amylase 126. The onset date of mumps was also reported as 02-JAN-2010. The outcome of the patient was not provided. Follow-up information was received from the physician indicating that the patient was 10 year old (previously reported as 12 years old) at the time of mumps onset. On 23-DEC-2009 (previously reported as 24-NOV-2009 and 02-JAN-2010) the patient developed mumps. On 24-DEC-2009 he was diagnosed with left parotitis. Patient was afebrile (previously reported as having fever of 103 F). First blood work was done on 24-DEC-2009 (results not provided). The outcome of the event was not provided. No further information is available.
Swelling and rash were immediate, then fever for 3 days then child was never the same, no eye contact moderate to severe autism diagnosis followed, recently test results have shown off the chart high aluminum poisoning.
Information has been received from a physician concerning a 23 year old female with a pertinent medical history of birth control medication who on 21-JUL-2009 was vaccinated with the first 0.5ml dose of GARDASIL. After getting the dose the patient experienced numbness on her right arm through neck until the jaw area. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. All telephone attempts to obtain follow-up information have been unsuccessful on 23-JUL-2009 and 27-JUL-2009. Follow-up information has been received from a physician concerning a 21 year old (previously reported as 23 year old) female patient with no illness at time of vaccination and no pre-existing allergies, birth defects or medical conditions who was vaccinated IM with the first dose of GARDASIL (Lot# 661764/0650X) in the right deltoid at 6:10pm on 21-JUL-2009. On 21-JUL-2009 after her vaccination she started to feel numbness on the right side of the neck which radiating to the right side of her face. She felt the same sensation on the right side of her mouth. On 22-JUL-2009 in the morning she saw that the right side of her face looked puffy and when she smiled she could see a difference between the right and left side of her face. Her co-workers noticed the puffiness of her right cheek. She had no difficulty swallowing. The physician reported that the right cheek showed a slight puffiness when compared to the left side and there was no difference on the nasolabial folds when she smiled. The physician advised the patient to take 25 mg po of unspecified medication now and repeat later that night. The patient had been advised to call if she felt that the symptoms were worsening. At the time of report the patient's status was recovered. Additional information is not expected.
I have had Covid more than once and my fully vaccinated/ boosted husband has been sicker than me each time; I have had Covid more than once and my fully vaccinated/ boosted husband has been sicker than me each time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I have had Covid more than once and my fully vaccinated/ boosted husband has been sicker than me each time". The reporter mentioned she have had Covid more than once and her fully vaccinated/ boosted husband has been sicker than her each time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
3 days after receiving the Pfizer COVID-19 vaccination, the patient reported numbness in her bilateral toes that progressed to numbness and weakness of her bilateral legs. 5 days after the onset of her initial symptoms, the patient noted bilateral numbness in her fingers and her mouth, that also progressed to weakness in her bilateral arms. A few days later, the patient noticed a right-sided facial droop that brought her to the ED. Given the patient's symptoms and elevated protein in the patient's CSF (obtained via lumbar puncture), the patient's symptoms are concerning for Guillain-Barre syndrome. The patient was started today on 5 days of immune globulin (PRIVIGEN) 10 % IV infusion 25 g.
Irregular period.  Frequency is now irregular and nearly every 2 weeks, compared to monthly cycles prior to vaccine,
muscle loss; Severe yeast infection; headache; confusion; This is a spontaneous report from a contactable consumer(patient).  A female non-pregnant patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 03Feb2021 (Batch/Lot Number: EM9810) as 1st dose, single dose for Covid-19 immunization. Medical history included ongoing High blood pressure, blood glucose abnormal, cholesterol and thyroid. Concomitant medications were not reported. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 24Feb2021 (Batch/Lot Number: EN6202) as 2 nd dose, single dose for covid-19 immunization. The patient had Covid-19 prior vaccination. Post vaccination patient not tested for covid-19. The patient did not receive any other vaccine in four weeks. On 05Feb2021 patient experienced headache, sever yeast infection, muscle loss and confusion. The events resulted in doctor or other healthcare professional office/clinic visit. The events treated with Premarin, Diflucan and Lotrisone. The patient had not yet recovered from events.   No follow -up attempts are possible. No further information is expected.
p/vax pt exp chickenpox;pt was seen in MD office;the reporter noted that some of the lesions had healed while other still has pustules;
Fever, chills, body aches, muscle spasms.  Seen by urgent care on 3AUG08.  Treated for possible "heat exhaustion".  Possible viral infec.
This case was reported by a other health professional via call center representative and described the occurrence of neuropathy in a patient who received FLUARIX QUADRIVALENT. On an unknown date, the patient received FLUARIX QUADRIVALENT. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT, the patient experienced neuropathy and tingling feet/hands. On an unknown date, the outcome of the neuropathy and tingling feet/hands were unknown. It was unknown if the reporter considered the neuropathy and tingling feet/hands to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that the patient experienced neuropathy, described as tingling in the hands and feet after receiving the FLUARIX QUADRIVALENT. The patient and product details were unknown but health care professional could be contacted by email for follow up.
VARIVAX has been administered to a total of 13 patients. Temperature -14°C up to-10°C for 2 hours 5 minutes 0 seconds ; -10°C up to 8°C (-0.4C) for 1 hour 25 minutes 0 seconds; No additional AE details; This spontaneous report was received from a costumer referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent.  On an unknown date, the patient was vaccinated with an improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX)  for prophylaxis (lot # U039949 has been verified to be a valid lot number varicella virus vaccine live (oka/merck), expiration date reported and establish as 16-DEC-2023) (strength, dose, route of administration and anatomical location were not provided).  The temperature of storage and time frame of the excursion were -14° Celsius (C) up to -10°C for 2 hours and 5 minutes and -10°C up to 8°C for 1 hour and 25 minutes respectively.  If a digital data logger was involved was not reported.  The vaccines experienced a previous temperature excursion of -14°C up to -10°C for 0 hours 50 minutes.  No adverse event reported.
The day after receiving the vaccine he complained of chills and fatigue that lasted 2 days and local  site injection redness pain and swelling. The third day he felt better, but the evening of the 15th he complained of left hand tingling and collapsed in a vfib arrest.
My 9 month old son went in to receive his "routine" vaccines and after getting the Hib, Pneumo conjugate, and HepB shots at around 9:30 am, he ended up going into a full-blown seizure later that night (at about 1 am). It was the most terrifying thing I ever experienced, our baby's whole body convulsed, his eyes were rolled back and his lips were turning blue! It lasted for almost 2 minutes and we had no idea if he was breathing. It was the scariest thing I've ever experienced and we will never forget that trauma. We thought vaccines were supposed to keep our baby safe and here we were calling 911 in the middle of the night because our small baby was having a seizure due to a vaccination! We took an ambulance ride to the ER and they observed him for a few hours after dosing him with Tylenol and Motrin (his fever was at 103.5 AFTER forty-five minutes of administering the liquid Tylenol and Motrin). So they kept him to make sure his fever would go down and to make sure he wouldn't have another seizure. It was a horrible, scary night. We believed the pediatricians when they said that vaccines were given to help keep our baby from getting sick and here we were in the ER with a sick baby because of a vaccination, how ironic. Later that morning, we immediately called the health dept. and told them what happened and they made a note of it in his file. Needless to say, he won't be getting any more injections because I can not see my baby like that ever again. The chance is too high that he could've not come out of it, or he could've had neurological damage. It was a huge wake up call. I used to roll my eyes at anti-vaxxers until this happened to us personally. Now I realize that it's not until you see your little baby go through something so horrible and scary that you question vaccines. Once it happens personally to you and the person you love the most, nothing is worth that chance that he could be hurt or damaged from a vaccine permanently.
Extreme sunburn, Ive been sunburnt in the past but this seemed to have made it way worse.; After being burnt 6 days ago its still bright red; Painful; Itchy; Blistery; This is a spontaneous report from a contactable consumer, the patient. A 40-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 28Apr2021 at 18:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient medical history included sunburn. The patient had no allergies to medications, food or other products. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right arm on 07Apr2021 at 18:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 the patient experienced extreme sunburn, erythema, pain, itchy and blister. (It was reported that the patient had extreme sunburn, she had been sunburnt in the past but this seemed to have made it way worse. After being burnt 6 days before it was still bright red, painful, itchy and blistery). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events extreme sunburn, erythema, pain, itchy and blistery was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a certified medical assistant refers to a 2 year old female patient. Pertinent medical history, drug reactions or allergies were not reported. On 30-DEC-2011, the patient was vaccinated with VAQTA (25/0.5) dose 1, 0.5 ml, intramuscular (lot# was not reported). On 25-JUL-2012, the patient was vaccinated with VAQTA (25/0.5) dose 2, 0.5 ml, intramuscular (lot# was not reported). No adverse effects reported. Additional information has been requested.
03Feb98 pt recv 1 dose vax. 18Feb98 pt devel fever. 19Feb98 pt devel approx 30 lesions on arm,face & chest. 20Feb98 she had over 200 lesions described as clear vesicles & pustules.24Feb98 pt had several hundred lesions. See comments
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. Between 01-AUG-2018 and 06-AUG-2018, the patients were vaccinated with an improperly stored VARIVAX subcutaneously, for prophylaxis, lot #N035940 and expiration date 18-DEC-2019 (strength, dose and frequency were not reported), which was reconstituted with a properly stored sterile diluent (MERCK). No adverse effects were reported. The temperatures of excursion were reported as 6°F to 14°F during a time frame of 1 hour and 15 minutes and 28.5°F during a time frame of 45 minutes. There was no previous temperature excursion reported. There was a digital data logger involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA009440: US-009507513-1808USA009441: US-009507513-1808USA009442: US-009507513-1808USA009443: US-009507513-1808USA009444: US-009507513-1808USA009446: US-009507513-1808USA009447: US-009507513-1808USA003515.
Vomiting 3-4 times beginning at 2:00 AM seen in office at 10:15 am; PEDIALYTE prescribed and ZOFRAN.
Patient reported tingling around mouth and in mouth after receiving vaccine while being observed.  BP was noted to be elevated at 180/100.  She was given 25 mg Benadryl by mouth and observed for an additional 15 minutes (total of 45 minutes).  Patient's symptoms improved and BP improved to 156/90.  Patient felt symptoms were resolved and she was allowed to leave after 45 minutes of monitoring.
pt recvd vax 1JUN94 & was found gagging, cold & pale; rushed to ER where dx shock p/8 hrs in PICU only dx cardiomyopathy;
Pt. states that after receiving the 2nd dose of Moderna 04/03/2021, started experiencing symptoms mid-04/2021 of fatigue, numbness in the hands (both), pain in the tendons with inflammation, and pain at the injection site. Primary visits (estimated 4 visits unknown) X-Rays preformed and determined age-related. X-ray preformed again *2 weeks ago stated (still determined age-related) Blood Work preformed with Markers for Inflammation. Still continuing to experience symptoms.
leg weakness; cold hands/cold feet; chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (leg weakness), PERIPHERAL COLDNESS (cold hands/cold feet) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21a) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced ASTHENIA (leg weakness), PERIPHERAL COLDNESS (cold hands/cold feet) and CHILLS (chills). On 17-Mar-2021, ASTHENIA (leg weakness) outcome was unknown. At the time of the report, PERIPHERAL COLDNESS (cold hands/cold feet) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Within 5 minutes dizziness, lightheadedness, throat stiffening, chest pain, vision difficulty lasting several hours.  Took aspirin and later an antihistamine.  Extreme arm pain lasting several days.
12/16/2013-. Swelling, redness, and warmth to all of arm injection was given in. Antihistime and ibuprofen given. 12/17/2013- Swelling, redness, warmth, and pain at still at site of injection.
Migraine  - Toradol - Received injection  Back, neck, chest pain Elevated blood pressure  Numbness/ pin needles in injected arm  -  prescribed Tizanidine for muscle spasms  Brain fog